Bridgebio pharma Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Bridgebio pharma Contact Number

421 Kipling Street, Palo Alto, CA 94301 | 650-391-9740 | [email protected]bridgebio[email protected]bridgebio.com

Contact US: https://bridgebio.com/

What kind of a company is bridgebio Inc?

BridgeBio is a company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. Charts can be found on various organization profiles and on Hubs pages, based on data availability.

What was the IPO price for bridgebio in 2019?

BridgeBio is a company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. Charts can be found on various organization profiles and on Hubs pages, based on data availability. BridgeBio is registered under the ticker NASDAQ:BBIO . Their stock opened with $17.00 in its Jun 26, 2019 IPO.

How does bridgebio turn scientific discovery into Patient Solutions?

Turning scientific discovery into patient solutions as fast as humanly possible. BridgeBio thanks the brave and dedicated physicians, nurses, first responders, and medical staff who are working tirelessly to care for patients with COVID-19 We're turning a biological problem into an engineering mission.

What can bridgebio do for patients with covid-19?

BridgeBio thanks the brave and dedicated physicians, nurses, first responders, and medical staff who are working tirelessly to care for patients with COVID-19 We're turning a biological problem into an engineering mission. Turning scientific discovery into patient solutions as fast as humanly possible.

Kipling

68 People Used

See More ››

Investor Contact BridgeBio Pharma

421 Kipling Street, Palo Alto, CA 94301 | 650-391-9740 | [email protected]bridgebio[email protected]bridgebio.com

View Contact ››

Bridgebio

117 People Used

See More ››

Bridgebio Pharma, Inc. Company Profile Palo Alto, CA

Bridgebio Pharma, Inc. is located in Palo Alto, CA, United States and is part of the Pharmaceutical Manufacturing Industry. Bridgebio Pharma, Inc. has 552 total employees across all of its locations and generates $8.25 million in sales (USD). There are 7 companies in the Bridgebio Pharma

View Contact ››

BridgeBio

53 People Used

See More ››

BridgeBio Pharma

Also Known As BridgeBio Pharma, Inc. Legal Name BridgeBio Inc. Stock Symbol NASDAQ:BBIO. Company Type For Profit. Number of Exits 2. Contact Email [email protected]bridgebio.com. Phone Number (650) 521-0894. BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.

View Contact ››

Arise

51 People Used

See More ››

BridgeBio Pharma IPOScoop

We founded BridgeBio in 2015 to identify and advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers.

View Contact ››

BridgeBio

63 People Used

See More ››

BridgeBio

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PALO ALTO, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases, today announced that on May 4, 2021, the compensation committee of BridgeBio’s board of directors granted 27 new employees restricted …

View Contact ››

Contact

49 People Used

See More ››

BridgeBio Pharma Vendor Enrollment

Contact Email * Contact Phone * Taxpayer ID Number ACH Routing Number (Domestic Vendors) (our) account at the Financial Institution listed above. If BridgeBio Pharma and/or its subsidiaries erroneously deposit funds into the said account, I (we) authorize BridgeBio Pharma and/or its subsidiaries and the Financial Institution to initiate

View Contact ››

Business

52 People Used

See More ››

BridgeBio Pharma, Inc. (BBIO) Company Profile & Facts

See the company profile for BridgeBio Pharma, Inc. (BBIO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and

View Contact ››

Development

55 People Used

See More ››

BridgeBio Pharma (BBIO) Company Profile & Overview Stock

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include BBP-265, a small molecule stabilizer of

View Contact ››

Founded

222 People Used

See More ››

BridgeBio Pharma, Inc. And Roswell Park Establish

Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at www.roswellpark.org, or contact

View Contact ››

Including

44 People Used

See More ››

About Us QED Therapeutics BridgeBio

Neil is the Chief Executive Officer and Founder of BridgeBio Pharma LLC, a company focused on the development of novel therapies for genetic diseases. Prior to founding BridgeBio, he held prominent roles with both established and emerging companies, including Principal at Third Rock Ventures, VP of Business Development and Operations for

View Contact ››

Please leave your comments here:

Popular Brands

Bce
Brf
Bmw
Bvb
Bpost